This work is licensed under the Creative Commons Attribution 4.0 International License.
Liehn EA, Ponomariov V, Diaconu R, Streata I, Ioana M, Crespo-Avilan GE, et al. Apolipoprotein E in cardiovascular diseases: novel aspects of an old-fashioned enigma. Arch Med Res. 2018;49(8):522–9.LiehnEAPonomariovVDiaconuRStreataIIoanaMCrespo-AvilanGEApolipoprotein E in cardiovascular diseases: novel aspects of an old-fashioned enigma.Arch Med Res.2018;49(8):522–9.Search in Google Scholar
Marais AD. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Pathology. 2019;51(2):165–76.MaraisAD.Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.Pathology.2019;51(2):165–76.Search in Google Scholar
Liehn EA, Lupan A-M, Diaconu R, Ioana M, Streata I, Manole C, et al. Heart function assessment during aging in apolipoprotein E knock-out mice. Discoveries. 2021;9(3):e136.LiehnEALupanA-MDiaconuRIoanaMStreataIManoleCHeart function assessment during aging in apolipoprotein E knock-out mice.Discoveries.2021;9(3):e136.Search in Google Scholar
Kharrazi H, Vaisi Raygani A, Sabokroh AR, Pourmotabbed T. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran. Clin Biochem. 2006;39(6): 613–6.KharraziHVaisi RayganiASabokrohARPourmotabbedT.Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran.Clin Biochem.2006;39(6):613–6.Search in Google Scholar
Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1,481–92.GrundySMPasternakRGreenlandPSmithSFusterV.Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.Circulation.1999;100(13):1,481–92.Search in Google Scholar
Cohn JS, Tremblay M, Boulet L, Jacques H, Davignon J, Roy M, et al. Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism. Atherosclerosis. 2003;169(1):63–70.CohnJSTremblayMBouletLJacquesHDavignonJRoyMPlasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism.Atherosclerosis.2003;169(1):63–70.Search in Google Scholar
Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8(1):1–21.DavignonJGreggRESingCF.Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis.1988;8(1):1–21.Search in Google Scholar
Dallongeville J, Roy M, Leboeuf N, Xhignesse M, Davignon J, Lussier-Cacan S. Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia. Arterioscler Thromb. 1991;11(2):272–8.DallongevilleJRoyMLeboeufNXhignesseMDavignonJLussier-CacanS.Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia.Arterioscler Thromb.1991;11(2):272–8.Search in Google Scholar
Yamamura T. Apolipoprotein E. Nihon Rinsho. (in Japanese) 1994;52(12):3,124–32.YamamuraT.Apolipoprotein E.Nihon Rinsho.(in Japanese)1994;52(12):3,124–32.Search in Google Scholar
Végh C, Langmár Z, Szerzo M, Agota A, Marosi K, Szabolcs Z, et al. Connections between apolipoprotein E genotypes and the development of cardiovascular diseases. (in Hungarian) Orv Hetil. 2012;153(52):2,070–6.VéghCLangmárZSzerzoMAgotaAMarosiKSzabolcsZConnections between apolipoprotein E genotypes and the development of cardiovascular diseases. (in Hungarian)Orv Hetil.2012;153(52):2,070–6.Search in Google Scholar
Wang XL, McCredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol. 1995;15(8):1,030–4.WangXLMcCredieRMWilckenDEL.Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography.Arterioscler Thromb Vasc Biol.1995;15(8):1,030–4.Search in Google Scholar
Stengård JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet. 1998;103(2):234–41.StengårdJHWeissKMSingCF.An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E.Hum Genet.1998;103(2):234–41.Search in Google Scholar
Lehtinen S, Lehtimäki T, Sisto T, Salenius JP, Nikkilä M, Jokela H, et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis. 1995;114(1):83–91.LehtinenSLehtimäkiTSistoTSaleniusJPNikkiläMJokelaHApolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.Atherosclerosis.1995;114(1):83–91.Search in Google Scholar
Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91(2):265–9.StengårdJHZerbaKEPekkanenJEhnholmCNissinenASingCF.Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men.Circulation.1995;91(2):265–9.Search in Google Scholar
Liu C-C, Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature reviews Neurology. 2013;9(2):106–18.LiuC-CLiuC-CKanekiyoTXuHBuG.Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.Nature reviews Neurology.2013;9(2):106–18.Search in Google Scholar
Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38(1):1–17.WardACreanSMercaldiCJCollinsJMBoydDCookMNPrevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer’s disease: a systematic review and meta-analysis.Neuroepidemiology.2012;38(1):1–17.Search in Google Scholar
Anuurad E, Rubin J, Lu G, Pearson TA, Holleran S, Ramakrishnan R, et al. Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res. 2006;47(11):2,475–81.AnuuradERubinJLuGPearsonTAHolleranSRamakrishnanRProtective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol.J Lipid Res.2006;47(11):2,475–81.Search in Google Scholar
Howard B V, Gidding SS, Liu K. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA study. Coronary artery risk development in young adults. Am J Epidemiol. 1998;148(9):859–68.HowardB VGiddingSSLiuK.Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA study. Coronary artery risk development in young adults.Am J Epidemiol.1998;148(9):859–68.Search in Google Scholar
Simionescu M, Bilan S, Gavurova B, Bordea EN. Health policies in Romania to reduce the mortality caused by cardiovascular diseases. Int J Environ Res Public Health. 2019;16(17):3,080.SimionescuMBilanSGavurovaBBordeaEN.Health policies in Romania to reduce the mortality caused by cardiovascular diseases.Int J Environ Res Public Health.2019;16(17):3,080.Search in Google Scholar
Sima A, Iordan A, Stancu C. Apolipoprotein E polymorphism-a risk factor for metabolic syndrome. Clin Chem Lab Med. 2007;45(9):1,149–53.SimaAIordanAStancuC.Apolipoprotein E polymorphism-a risk factor for metabolic syndrome.Clin Chem Lab Med.2007;45(9):1,149–53.Search in Google Scholar
Main BF, Jones PJH, MacGillivray RTA, Banfield DK. Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide primers. J Lipid Res. 1991;32(1):183–7.MainBFJonesPJHMacGillivrayRTABanfieldDK.Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide primers.J Lipid Res.1991;32(1):183–7.Search in Google Scholar
Diaconu R, Schaaps N, Afify M, Boor P, Cornelissen A, Florescu RA, et al. Apolipoprotein e4 is associated with right ventricular dysfunction in dilated cardiomyopathy–an animal and in-human comparative study. Int J Mol Sci. 2021;22(18):9,688.DiaconuRSchaapsNAfifyMBoorPCornelissenAFlorescuRAApolipoprotein e4 is associated with right ventricular dysfunction in dilated cardiomyopathy–an animal and in-human comparative study.Int J Mol Sci.2021;22(18):9,688.Search in Google Scholar
Vučinić N, Djan I, Stokić E, Božin B, Obreht D, Stankov K, et al. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Mol Biol Rep. 2014;41(8):5,221–7.VučinićNDjanIStokićEBožinBObrehtDStankovKDifferent associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia).Mol Biol Rep.2014;41(8):5,221–7.Search in Google Scholar
Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991;49(2):338–49.HallmanDMBoerwinkleESahaNSandholzerCMenzelHJCsazarAThe apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.Am J Hum Genet.1991;49(2):338–49.Search in Google Scholar
Kalina A, Szalai C, Prohászka Z, Reiber I, Császár A. Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes. Diabetes Res Clin Pract. 2002;56(1):63–8.KalinaASzalaiCProhászkaZReiberICsászárA.Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes.Diabetes Res Clin Pract.2002;56(1):63–8.Search in Google Scholar
Borinskaia SA, Kal’ina NR, Sanina ED, Kozhekbaeva ZM, Gupalo EI, Garmash I V, et al. Polymorphism of the apolipoprotein E gene (APOE) in the populations of Russia and neighboring countries. (in Russian) Genetika. 2007;43(10):1,434–40.BorinskaiaSAKal’inaNRSaninaEDKozhekbaevaZMGupaloEIGarmashI VPolymorphism of the apolipoprotein E gene (APOE) in the populations of Russia and neighboring countries. (in Russian)Genetika.2007;43(10):1,434–40.Search in Google Scholar
Siváková D, Zacharová M, Gasparovic J, Raslová K, Wsólová L, Basistová Z, et al. Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. Coll Antropol. 2006;30(2):387–94.SivákováDZacharováMGasparovicJRaslováKWsólováLBasistováZApolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia.Coll Antropol.2006;30(2):387–94.Search in Google Scholar
Borilova Linhartova P, Bartova J, Poskerova H, Machal J, Vokurka J, Fassmann A, et al. Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels. Arch Oral Biol. 2015;60(3):456–62.Borilova LinhartovaPBartovaJPoskerovaHMachalJVokurkaJFassmannAApolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels.Arch Oral Biol.2015;60(3):456–62.Search in Google Scholar
Kowalska A, Wiechmann I, Walter H. Genetic variability of apolipoprotein E in a Polish population. Hum Biol;70(6):1,093–9.KowalskaAWiechmannIWalterH.Genetic variability of apolipoprotein E in a Polish population.Hum Biol;70(6):1,093–9.Search in Google Scholar
Pedersen JC, Berg K. Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels. Clin Genet. 1990;38(4):287–94.PedersenJCBergK.Gene-gene interaction between the low density lipoprotein receptor and apolipoprotein E loci affects lipid levels.Clin Genet.1990;38(4):287–94.Search in Google Scholar
Roussos L, Ekström U, Ehle PN, Öqvist B, Floren CH. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden. Scand J Urol Nephrol. 2004;38(6):504–10.RoussosLEkströmUEhlePNÖqvistBFlorenCH.Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.Scand J Urol Nephrol.2004;38(6):504–10.Search in Google Scholar
Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993;39(10):2,125–9.EggertsenGTegelmanREricssonSAngelinBBerglundL.Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations.Clin Chem.1993;39(10):2,125–9.Search in Google Scholar
Lehtimaki T, Uibu T, Roto P, Koivula T, Jokela H, Ehnholm C, et al. Apolipoprotein E and A-IV polymorphisms in the Estonian population. Clin Genet. 1998;54(1):106–7.LehtimakiTUibuTRotoPKoivulaTJokelaHEhnholmCApolipoprotein E and A-IV polymorphisms in the Estonian population.Clin Genet.1998;54(1):106–7.Search in Google Scholar
Petkeviciene J, Smalinskiene A, Luksiene DI, Jureniene K, Ramazauskiene V, Klumbiene J, et al. Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population. PLoS One. 2012;7(7):e41525.PetkevicieneJSmalinskieneALuksieneDIJurenieneKRamazauskieneVKlumbieneJAssociations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population.PLoS One.2012;7(7):e41525.Search in Google Scholar
Gerdes LU, Klausen IC, Sihm I, Faergeman O, Vogler GP. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol. 1992;9(3):155–67.GerdesLUKlausenICSihmIFaergemanOVoglerGP.Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.Genet Epidemiol.1992;9(3):155–67.Search in Google Scholar
Sheehan D, Bennett T, Cashman K. Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk. Ir J Med Sci. 2000;169(1):50–4.SheehanDBennettTCashmanK.Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk.Ir J Med Sci.2000;169(1):50–4.Search in Google Scholar
Adler G, Adler MA, Urbańska A, Skonieczna-Żydecka K, Kiseljakovic E, Valjevac A, et al. Bosnian study of APOE distribution (BOSAD): a comparison with other European populations. Ann Hum Biol. 2017;44(6):568–73.AdlerGAdlerMAUrbańskaASkonieczna-ŻydeckaKKiseljakovicEValjevacABosnian study of APOE distribution (BOSAD): a comparison with other European populations.Ann Hum Biol.2017;44(6):568–73.Search in Google Scholar
Mustapic M, Popovic Hadzija M, Pavlovic M, Pavkovic P, Presecki P, Mrazovac D, et al. Alzheimer’s disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes. Metab Brain Dis. 2012;27(4):507–12.MustapicMPopovic HadzijaMPavlovicMPavkovicPPreseckiPMrazovacDAlzheimer’s disease and type 2 diabetes: the association study of polymorphisms in tumor necrosis factor-alpha and apolipoprotein E genes.Metab Brain Dis.2012;27(4):507–12.Search in Google Scholar
Gialeraki A, Politou M, Rallidis L, Merkouri E, Markatos C, Kremastinos D, et al. Prevalence of prothrombotic polymorphisms in Greece. Genet Test. 2008;12(4):541–7.GialerakiAPolitouMRallidisLMerkouriEMarkatosCKremastinosDPrevalence of prothrombotic polymorphisms in Greece.Genet Test.2008;12(4):541–7.Search in Google Scholar
Haddy N, De Bacquer D, Chemaly MM, Maurice M, Ehnholm C, Evans A, et al. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet. 2002;10(12):841–50.HaddyNDe BacquerDChemalyMMMauriceMEhnholmCEvansAThe importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe.Eur J Hum Genet.2002;10(12):841–50.Search in Google Scholar
Muros M, Rodríguez-Ferrer C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis. 1996;121(1):13–21.MurosMRodríguez-FerrerC.Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4.Atherosclerosis.1996;121(1):13–21.Search in Google Scholar
Schmidt R, Schmidt H, Fazekas F, Schumacher M, Niederkorn K, Kapeller P, et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke. 1997;28(5):951–6.SchmidtRSchmidtHFazekasFSchumacherMNiederkornKKapellerPApolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study.Stroke.1997;28(5):951–6.Search in Google Scholar
Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE * 4 a ‘thrifty’ allele? Ann Hum Genet. 1999;63(4):301–10.CorboRMScacchiR.Apolipoprotein E (APOE) allele distribution in the world. Is APOE * 4 a ‘thrifty’ allele?Ann Hum Genet.1999;63(4):301–10.Search in Google Scholar
Bailleul S, Couderc R, Landais V, Lefèvre G, Raichvarg D, Etienne J. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum Hered. 1993;43(3):159–65.BailleulSCoudercRLandaisVLefèvreGRaichvargDEtienneJ.Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France).Hum Hered.1993;43(3):159–65.Search in Google Scholar
Klasen EC, Smit M, Knijff P De, Leuven JG, Kempen-Voogd R, Havekes L. Apolipoprotein E phenotype and gene distribution in The Netherlands. Hum Hered. 1987;37(6):340–4.KlasenECSmitMKnijffP DeLeuvenJGKempen-VoogdRHavekesL.Apolipoprotein E phenotype and gene distribution in The Netherlands.Hum Hered.1987;37(6):340–4.Search in Google Scholar
Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet. 1993;1(1):3–18.Cavalli-SforzaLLPiazzaA.Human genomic diversity in Europe: a summary of recent research and prospects for the future.Eur J Hum Genet.1993;1(1):3–18.Search in Google Scholar
Veeramah KR, Novembre J. Demographic events and evolutionary forces shaping European genetic diversity. Cold Spring Harb Perspect Biol. 2014;6(9):a008516.VeeramahKRNovembreJ.Demographic events and evolutionary forces shaping European genetic diversity.Cold Spring Harb Perspect Biol.2014;6(9):a008516.Search in Google Scholar
Atadzhanov M, Mwaba MH, Mukomena PN, Lakhi S, Mwaba P, Rayaprolu S, et al. Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population. BMC Res Notes. 2014;7:194.AtadzhanovMMwabaMHMukomenaPNLakhiSMwabaPRayaproluSFrequency of APOE, MTHFR and ACE polymorphisms in the Zambian population.BMC Res Notes.2014;7:194.Search in Google Scholar
Cocoş R, Schipor S, Hervella M, Cianga P, Popescu R, Banescu C, et al. Genetic affinities among the historical provinces of Romania and Central Europe as revealed by an mtDNA analysis. BMC Genet. 2017;18(1):20.CocoşRSchiporSHervellaMCiangaPPopescuRBanescuCGenetic affinities among the historical provinces of Romania and Central Europe as revealed by an mtDNA analysis.BMC Genet.2017;18(1):20.Search in Google Scholar
Hedenstierna-Jonson C, Kjellström A, Zachrisson T, Krzewińska M, Sobrado V, Price N, et al. A female Viking warrior confirmed by genomics. Am J Phys Anthropol. 2017;164(4):853–60.Hedenstierna-JonsonCKjellströmAZachrissonTKrzewińskaMSobradoVPriceNA female Viking warrior confirmed by genomics.Am J Phys Anthropol.2017;164(4):853–60.Search in Google Scholar
Hellenthal G, Busby GBJ, Band G, Wilson JF, Capelli C, Falush D, et al. A genetic atlas of human admixture history. Science. 2014;343(6,172):747–51.HellenthalGBusbyGBJBandGWilsonJFCapelliCFalushDA genetic atlas of human admixture history.Science.2014;343(6,172):747–51.Search in Google Scholar
Gaiţǎ D, Moşteoru S. Cardiometabolic prevention in Romania: a midsummer night’s dream? Cardiovasc Endocrinol. 2017;6(1):45–7.GaiţǎDMoşteoruS.Cardiometabolic prevention in Romania: a midsummer night’s dream?Cardiovasc Endocrinol.2017;6(1):45–7.Search in Google Scholar
Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20(1):68–80.Serrano-PozoADasSHymanBT.APOE and Alzheimer’s disease: advances in genetics, pathophysiology, and therapeutic approaches.Lancet Neurol.2021;20(1):68–80.Search in Google Scholar
Kurki SN, Kantonen J, Kaivola K, Hokkanen L, Mäyränpää MI, Puttonen H, et al. APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study. Acta Neuropathol Commun. 2021;9(1):199.KurkiSNKantonenJKaivolaKHokkanenLMäyränpääMIPuttonenHAPOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study.Acta Neuropathol Commun.2021;9(1):199.Search in Google Scholar
Villeneuve S, Brisson D, Marchant NL, Gaudet D. The potential applications of Apolipoprotein E in personalized medicine. Front Aging Neurosci. 2014;6:154.VilleneuveSBrissonDMarchantNLGaudetD.The potential applications of Apolipoprotein E in personalized medicine.Front Aging Neurosci.2014;6:154.Search in Google Scholar
Donnelly LA, Palmer CN, Whitley AL, Lang CC, Doney AS, Morris AD, Donnan PT. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study. Pharmacogenet Genomics. 2008;18(4):279–87.DonnellyLAPalmerCNWhitleyALLangCCDoneyASMorrisADDonnanPT.Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.Pharmacogenet Genomics.2008;18(4):279–87.Search in Google Scholar
Cai C, Wen Z, Li L. The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia. Am J Transl Res. 2021;13(6):6,772–7.CaiCWenZLiL.The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia.Am J Transl Res.2021;13(6):6,772–7.Search in Google Scholar
Norwitz NG, Saif N, Ariza IE, Isaacson RS. Precision nutrition for Alzheimer’s prevention in ApoE4 carriers. Nutrients. 2021;13:1,362.NorwitzNGSaifNArizaIEIsaacsonRS.Precision nutrition for Alzheimer’s prevention in ApoE4 carriers.Nutrients.2021;13:1,362.Search in Google Scholar
Dagliati A, Peek N, Brinton RD, Geifman N. Sex and APOE genotype differences related to statin use in the aging population. Alzheimers Dement (N Y). 2021;7:e12156.DagliatiAPeekNBrintonRDGeifmanN.Sex and APOE genotype differences related to statin use in the aging population.Alzheimers Dement (N Y).2021;7:e12156.Search in Google Scholar